Why Cannabis May Not Relieve Anxiety or Depression
Emerging research on cannabis efficacy mood disorders shows mixed results for anxiety and depression relief. Many patients use cannabis products hoping for symptom improvement, but clinical evidence remains limited. Clinicians must address these evidence…
CBD Gummies Indication: What the Evidence Shows for Everyday Wellness
CBD gummies for lung health are increasingly popular, but clinical evidence remains limited. This article reviews what rigorous studies show about their therapeutic potential. Understanding cbd gummies for lung health helps clinicians guide patients…
Emerging Cannabis-Related Colorectal Cancer Treatment Research
Cannabis-related colorectal cancer treatment is currently being tested in clinical trials in West Michigan. This emerging research focuses on potential therapeutic effects and symptom management. Clinicians await peer-reviewed data to evaluate its…
Aengus Bridgman on How Algorithms Perpetuate Disinformation in Cannabis Medicine
Algorithmic amplification cannabis misinformation significantly impacts patient safety and clinical decision-making. Understanding these dynamics helps clinicians educate patients effectively. This focus on cannabis misinformation algorithms is crucial…
What the Medical Examiner Said as Levi Trial Heads to Closing Statements
This article reviews the medical examiner testimony cannabis evidence presented during the Levi trial. The clinical commentary highlights the importance of toxicology findings in legal medicine. Understanding this testimony is crucial for evidence-based…
Clinical Implications of Real-World Evidence from the CARE Study [Response to Letter]
Clinical implications real world evidence from the CARE study provide valuable insights into medical cannabis outcomes. This research bridges gaps left by controlled trials by capturing diverse patient experiences. Understanding this evidence helps…
New Study Highlights Cannabis Impairment and Clinical Evidence
This article discusses cannabis impairment evidence-based medicine from a recent Washington State University study. The study highlights clinical relevance in assessing cannabis use impairment. Understanding this evidence is crucial for informed clinical…
CBD Shows Promise But Lacks Broad Regulatory Approval: A Sobering Review of the Evidence
The CBD pharmacology regulatory context reveals a narrow evidence base supporting broad approval. Most CBD products lack pharmaceutical-grade quality and regulatory endorsement. This 2024 review highlights the need for rigorous clinical trials and…
Most European Countries Lack Evidence-Based Cannabis-Specific Treatment
Cannabis-specific treatment programs Europe remain limited and often lack evidence-based approaches. This 2025 overview reveals fragmented services with insufficient coverage. Structured psychosocial interventions are the most supported treatments for…
Bridging the Regulatory Chasm in Investigator‐Initiated Cannabis Research
Investigator initiated cannabis research barriers limit clinical studies and evidence-based medicine. Regulatory challenges impede rigorous cannabis research needed for informed decisions. Understanding these barriers is key to advancing cannabis…